Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Kilbourn

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Nuclear Medicine and Biology|March 19, 2004
In vivo evaluation of new carfentanil-based radioligands for the mu opiate receptorDouglas M Jewett, Michael R Kilbourn
ACS Chemical Neuroscience|September 11, 2018
Classics in Neuroimaging: Radioligands for the Vesicular Monoamine Transporter 2Michael R Kilbourn, Robert A Koeppe
Nuclear Medicine and Biology|September 14, 2018
Issues in preclinical radiopharmaceutical research: Significance, relevance and reproducibilityMichael R Kilbourn, Peter J H Scott
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 22, 2007
Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human usePeter J H Scott, Michael R Kilbourn
Nuclear Medicine and Biology|November 5, 2017
Is logP truly dead?Michael R Kilbourn, Peter J H Scott
Synapse (New York, N.Y.)|January 17, 2002
In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studiesMichael R Kilbourn, Phillip S Sherman, Kyle Kuszpit
ACS Central Science|September 10, 2016
Radiochemistry, PET Imaging, and the Internet of Chemical ThingsStephen Thompson, Michael R Kilbourn, Peter J H Scott
Nuclear Medicine and Biology|March 28, 2009
Specific to nonspecific binding in radiopharmaceutical studies: it's not so simple as it seems!William C Eckelman, Michael R Kilbourn, Chester A Mathis
Bioorganic & Medicinal Chemistry|March 23, 2005
[11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type miceNabeel B Nabulsi, David E Smith, Michael R Kilbourn
Nuclear Medicine and Biology|October 19, 2006
Radiopharmaceutical spaceWilliam C Eckelman, Michael R Kilbourn, Chester A Mathis
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Nuclear Medicine and Biology|March 19, 2004
In vivo evaluation of new carfentanil-based radioligands for the mu opiate receptorDouglas M Jewett, Michael R Kilbourn
ACS Chemical Neuroscience|September 11, 2018
Classics in Neuroimaging: Radioligands for the Vesicular Monoamine Transporter 2Michael R Kilbourn, Robert A Koeppe
Nuclear Medicine and Biology|September 14, 2018
Issues in preclinical radiopharmaceutical research: Significance, relevance and reproducibilityMichael R Kilbourn, Peter J H Scott
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|June 22, 2007
Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human usePeter J H Scott, Michael R Kilbourn
Nuclear Medicine and Biology|November 5, 2017
Is logP truly dead?Michael R Kilbourn, Peter J H Scott
Synapse (New York, N.Y.)|January 17, 2002
In vivo measures of dopaminergic radioligands in the rat brain: equilibrium infusion studiesMichael R Kilbourn, Phillip S Sherman, Kyle Kuszpit
ACS Central Science|September 10, 2016
Radiochemistry, PET Imaging, and the Internet of Chemical ThingsStephen Thompson, Michael R Kilbourn, Peter J H Scott
Nuclear Medicine and Biology|March 28, 2009
Specific to nonspecific binding in radiopharmaceutical studies: it's not so simple as it seems!William C Eckelman, Michael R Kilbourn, Chester A Mathis
Bioorganic & Medicinal Chemistry|March 23, 2005
[11C]Glycylsarcosine: synthesis and in vivo evaluation as a PET tracer of PepT2 transporter function in kidney of PepT2 null and wild-type miceNabeel B Nabulsi, David E Smith, Michael R Kilbourn
Nuclear Medicine and Biology|October 19, 2006
Radiopharmaceutical spaceWilliam C Eckelman, Michael R Kilbourn, Chester A Mathis
Pageof 8